Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Masimo Total Hemoglobin SpHb® Continuous Non-invasive Hemoglobin Monitoring Device With Laboratory Complete Blood Count Measurement Using Venous Sample: A Substudy of the Pregnancy Risk Stratification Innovation and Measurement Alliance Maternal and Newborn Health (PRiSMA MNH) Study

NCT05656352 is registered in ClinicalTrials.gov with George Washington University as lead sponsor.

NCT NCT05656352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05656352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Masimo Total Hemoglobin SpHb® Continuous Non-invasive Hemoglobin Monitoring Device With Laboratory Complete Blood Count Measurement Using Venous Sample: A Substudy of the Pregnancy Risk Stratification Innovation and Measurement Alliance Maternal and Newborn Health (PRiSMA MNH) Study
Lead sponsor
George Washington University
Phase
Observational
Overall status
Completed
Start date
September 22, 2022
Completion date
January 24, 2024
Enrollment
900 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

pregnancy, high risk